Biotech

All Articles

ArsenalBio elevates $325M, pivots off of previous lead asset

.Collection Biosciences is actually proceeding up. The tissue treatment company has added $325 thous...

Lilly- supported weight-loss biotech files IPO

.After elevating $170 million back in February, metabolic disease-focused BioAge Labs has actually f...

Aelis' marijuana usage medicine flunks phase 2b, driving Indivior to rethink $100M option

.Aelis Farma's hopes of safeguarding a quick, favorable decision on a $one hundred million alternati...

ProKidney standstills stage 3 test not needed for tissue therapy confirmation

.ProKidney has stopped among a set of phase 3 tests for its own cell treatment for kidney health con...

Vaxcyte surges on 'impressive' 31-valent PCV win versus Pfizer

.Vaxcyte revealed what analysts called "impressive" stage 1/2 information for its own 31-valent pneu...

Recursion's mind disease trial reveals scant evidence of efficiency

.Recursion has stumbled by means of a very early test of its own tech-enabled approach to medicine r...

Acepodia, Pfizer click on together for chemistry-based cell therapy

.Contact it a scenario of good chemistry: Acepodia, a biotech based on Nobel Champion science, is ac...

Praxis epilepsy drug decreases seizures in period 2 litigation

.Practice Accuracy Medicines has scored yet another midphase gain in epilepsy this year, with its ow...

Three execs resign as Dyne articles blended information for DMD candidate

.After running away a medical grip numerous years back, Dyne Therapy has actually exposed brand new ...

Arrowhead fires off stage 3 records in rare metabolic ailment in advance of market clash with Ionis

.Arrowhead Pharmaceuticals has actually presented its own give in front of a potential face-off alon...